MedTrace Logo

The Effects of Preoperative Blood Flow Restriction Training in Patients Undergoing ACL Reconstruction

NCT06342063 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2024-04-02

No results posted yet for this study

Summary

This prospective feasibility study is designed to assess pre-operative BFR in patients awaiting ACL reconstruction. This study will serve the following: (1) to determine if BFR improves strength testing prior to surgery and (2) to determine if BFR reduces QF muscle group atrophy prior to surgery. Additionally, preliminary results on pre-operative clinical and quality of life scores will be collected. If this study shows encouraging results, it will serve as a template for a more comprehensive randomized control trial.

Conditions

  • ACL Injury
  • Sports Physical Therapy

Interventions

DEVICE

Blood Flow Restriction Therapy

Patients wear a personalized tourniquet pressure system on their involved thigh while they perform a series of leg press machine exercises. This tourniquet is inflated.

DEVICE

Blood Flow Restriction Therapy Sham

Patients wear a personalized tourniquet pressure system on their involved thigh while they perform a series of leg press machine exercises. This tourniquet is not inflated.

Sponsors & Collaborators

  • Women's College Hospital

    lead OTHER

Principal Investigators

  • John Theodoropoulos, MD, FRCSC · Dovigi Sports Medicine Clinic, Mount Sinai Hospital, Toronto, Canada

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2023-10-31
Completion
2024-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06342063 on ClinicalTrials.gov